Title : Factors influencing hematologic toxicity of radioimmunotherapy with 131I-labeled anti-carcinoembryonic antigen antibodies.

Pub. Date : 1997 Dec 15

PMID : 9406734






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Factors influencing hematologic toxicity of radioimmunotherapy with 131I-labeled anti-carcinoembryonic antigen antibodies. Iodine-131 CEA cell adhesion molecule 3 Homo sapiens
2 The authors investigated various factors potentially affecting hematologic toxicity after RAIT with 131I-labeled anti-carcinoembryonic antigen (CEA) MoAb to identify the statistically significant factors from those commonly perceived clinically to substantially contribute to this toxicity. Iodine-131 CEA cell adhesion molecule 3 Homo sapiens
3 The authors investigated various factors potentially affecting hematologic toxicity after RAIT with 131I-labeled anti-carcinoembryonic antigen (CEA) MoAb to identify the statistically significant factors from those commonly perceived clinically to substantially contribute to this toxicity. Iodine-131 CEA cell adhesion molecule 3 Homo sapiens
4 METHODS: Ninety-nine patients who received 131I-labeled anti-CEA MoAb for the treatment of CEA-producing cancers were assessed for platelet and white blood cell toxicity based on the common Radiation Therapy Oncology Group criteria. Iodine-131 CEA cell adhesion molecule 3 Homo sapiens
5 METHODS: Ninety-nine patients who received 131I-labeled anti-CEA MoAb for the treatment of CEA-producing cancers were assessed for platelet and white blood cell toxicity based on the common Radiation Therapy Oncology Group criteria. Iodine-131 CEA cell adhesion molecule 3 Homo sapiens